Neil here.

Countries around the world are slowly reopening one by one, but the harsh reality is that the coronavirus is still with us.

This is more than just a public health crisis. It’s a catch-22 situation of the most unprecedented kind.

According to top medical experts, if we lift strict public health measures too soon, we’re likely to see a severe increase in new cases of the virus. And even if the number of new cases begins to slow down during the summer, there is a very real threat of a second wave later in the year.

But waiting too long to reopen will only exacerbate an economic crisis that’s already taken a harsh toll on the global markets.

All of that to say: The only way to return to normalcy is if we can create a vaccine… fast.

We’ve heard infectious disease expert Dr. Anthony Fauci call the potential for a COVID vaccine a “game changer.” Now, I’m no public health expert, but I believe him.

Here’s the thing, though. Vaccines take serious time. I’m talking up to 10 years.

In the United States, the FDA has a rigorous process for vaccine approval that’s full of clinical trials, advisory hearings, inspections, follow-up studies, and more. Under normal circumstances, we’d be waiting a long time to see any significant vaccine development.

But life isn’t normal right now, and we don’t have years to wait. We need a vaccine right now, and the FDA knows that… so they’ve changed the rules.

They’ve issued an “Emergency Use Authorization” that will allow companies to sell clinical vaccines without going through their usual approval process.

This Federal fast-tracking means that a successful vaccine could arrive way sooner than we think… and where there’s incredible progress like that, there’s also a whole lot of money to be made.

Because people who claim their stake in a company that’s developing this vaccine before it pushes toward worldwide distribution have the potential to see some unbelievable gains.

Think about it. When all is said and done, seven billion people could end up needing this vaccine.

And the company who lands on the right cocktail could potentially see billions of dollars in revenue from distributing it across the world… which could produce an earth-shattering amount of money for investors.

There’s only one problem.

Dozens of companies are currently competing to produce a successful vaccine right now, and in such a crowded space, it can be hard to know exactly which vaccine is likely to hit the market first. But to see those types of returns, you’ve got to place your bets on the right companies.

Luckily, I know just the guy with the answers… and you’re about to get the inside scoop on a tiny company that’s well on its way to producing a workable vaccine by the end of June. That’s just one month away.

This company has already seen success with a vaccine for MERS… a respiratory virus that’s very similar to COVID-19. Essentially, this means that they broke ground on a COVID-19 vaccine well before it started, and we’re on the doorstep of some potentially life-changing results.

And because this company is so small, those who claim their stake right now could see some massive growth potential very soon… I’m talking about potential returns of at least 3,000%.

I’ve got all the information coming your way tomorrow, so stick around. You won’t want to miss out on this.

Until then,

Neil Patel